查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2052193

北美獸藥市場：市場洞察、競爭格局及市場預測（2033 年）

North America Vet Compounding Pharmacies Market Insights, Competitive Landscape, and Market Forecast - 2033
出版日期: | 出版商: Fairfield Market Research | 英文 194 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

受個人化動物醫藥需求不斷成長的推動，北美獸藥市場持續穩定擴張。對於那些無法使用大量生產的藥品有效治療的動物，藥局在配製個人化劑量和配方方面發揮著至關重要的作用。預計該市場將從2026年的17億美元成長到2033年的29億美元，預測期內年複合成長率（CAGR）為7.80%。寵物數量的增加、獸醫學的進步以及人們對動物健康意識的提高是推動該行業的主要因素。獸醫專業人員越來越依賴藥局來滿足獨特的劑量需求、提高遵守用藥並改善伴侶動物和牲畜的治療效果。

市場洞察：

隨著醫藥創新與獸醫學的強大聯合，該市場正不斷發展演變。北美市場結構高度規範，這得益於其先進的醫療保健基礎設施和在寵物醫療保健方面的巨額支出。複方製劑在動物疼痛管理、皮膚病治療、荷爾蒙療法和慢性病治療的應用日益廣泛。消費者對口味適宜且易於給藥的製劑的偏好不斷成長，進一步推動了市場需求。此外，藥物製劑技術的進步和嚴格的法律規範也在重塑整個藥房的營運標準。

促進因素：

推動市場成長的主要因素包括寵物飼養率的上升、動物慢性病盛行率的增加以及寵物「擬人化」趨勢的日益盛行。飼主越來越願意投資專業治療，這推動了對個人動物用藥品的需求。此外，市售動物用藥品的短缺促使獸醫探索配製替代方案。獸醫院和診所網路的擴張也促進了市場成長。

商業機會：

該市場為製藥公司和藥房拓展服務範圍提供了巨大的成長機會。數位化處方平台和遠端獸醫服務正在開闢新的分銷管道。對自動化配藥系統和品質保證技術的投資可以顯著提高效率和擴充性。預計獸醫和藥房之間的合作將日益增多，從而帶來長期的業務成長前景。

區域分析：

美國憑藉龐大的寵物數量和完善的獸醫保健體系，在北美動物藥局市場佔據主導地位。加拿大也正經歷穩定成長，這得益於人們日益增強的動物健康意識和完善的法規結構。特別是都市區，由於寵物擁有率高且獸醫服務便利，需求成長尤為顯著。此外，該地區也受惠於強大的研發投入和許多知名製藥公司的進駐。

主要公司：

  • Hoye's Pharmacy
  • Vertisis Custom Pharmacy
  • Smith Caldwell Drug Store
  • Sixth Avenue Medical Pharmacy
  • Dougherty Pharmacy
  • Triangle Compounding Pharmacy Inc.,
  • Wedgewood Pharmacy
  • Millers Pharmacy
  • Chiron Compounding Pharmacy
  • MEDS Canadian Compounding Pharmacy

市場區隔

依產品類型：

  • 中樞神經系統藥物
  • 抗感染藥物
  • 激素和激素替代藥物
  • 抗發炎藥
  • 其他

依動物類型：

  • 伴侶動物
  • 家畜

按劑型：

  • 口服
  • 注射
  • 其他

按地區分類：

  • 北美洲
  • 歐洲
  • 拉丁美洲
  • 東亞
  • 南亞和大洋洲
  • 中東和非洲

目錄

第1章執行摘要

第2章 市場概覽

  • 市場定義與細分
  • 市場動態
    • 促進因素
    • 抑制因子
    • 市場機遇
  • 價值鏈分析
  • 新冠疫情影響分析
  • 波特五力分析
  • 俄烏衝突的影響
  • PESTLE分析
  • 監管分析
  • 價格趨勢分析
    • 當前價格及未來預測（2025-2033）
    • 價格影響因素

第3章：2020-2033年北美獸藥市場展望

  • 北美獸藥市場展望，依產品類型分類，價值（十億美元），2020-2033年
    • 促效劑
    • 抗感染劑
    • 荷爾蒙及其替代療法
    • 抗發炎藥
  • 北美獸藥市場展望（按動物類型分類，價值單位：十億美元），2020-2033年
    • 伴侶動物
    • 家畜
  • 北美獸藥市場展望（以劑型分類，價值單位：十億美元），2020-2033年
    • 口服
    • 注射
    • 其他
  • 北美獸藥市場展望（按地區分類，價值單位：十億美元），2020-2033年
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第4章：2020-2033年北美獸藥市場展望

第5章：2020-2033年歐洲獸藥市場展望

第6章：2020-2033年亞太地區獸藥市場展望

第7章：2020-2033年拉丁美洲獸藥市場展望

第8章：2020-2033年中東和非洲獸藥市場展望

第9章 競爭情勢

  • 公司與細分市場熱圖
  • 2025年各公司市佔率分析
  • 競爭對手儀錶板
  • 公司簡介
    • Hoye's Pharmacy
    • Vertisis Custom Pharmacy
    • Smith Caldwell Drug Store
    • Sixth Avenue Medical Pharmacy
    • Dougherty Pharmacy
    • Triangle Compounding Pharmacy Inc.,
    • Wedgewood Pharmacy
    • Millers Pharmacy
    • Chiron Compounding Pharmacy
    • MEDS Canadian Compounding Pharmacy

第10章附錄

簡介目錄

The North America vet compounding pharmacies market is witnessing steady expansion driven by rising demand for personalized veterinary medications. Compounding pharmacies play a critical role in preparing customized dosages and formulations for animals that cannot be treated effectively with mass-produced drugs. The market is projected to grow from US$ 1.7 Bn in 2026 to US$ 2.9 Bn by 2033, registering a CAGR of 7.80% during the forecast period. Increasing pet ownership, advanced veterinary care, and growing awareness of animal health are key factors shaping the industry landscape. Veterinary professionals increasingly rely on compounding pharmacies to address unique dosage requirements, improve compliance, and enhance therapeutic outcomes across companion and livestock animals.

Market Insights:

The market is evolving with strong integration of pharmaceutical innovation and veterinary science. North America remains a highly structured market due to advanced healthcare infrastructure and high expenditure on pet healthcare. Compounded medications are increasingly used for pain management, dermatology, hormonal therapies, and chronic disease treatment in animals. The growing preference for flavored and easy-to-administer formulations is further boosting demand. Technological advancements in drug formulation and stringent regulatory oversight are also shaping operational standards across pharmacies.

Drivers:

Key drivers include rising pet adoption rates, increasing prevalence of chronic diseases among animals, and a growing trend of humanization of pets. Owners are increasingly willing to invest in specialized treatments, fueling demand for customized veterinary drugs. Additionally, shortages of commercially available veterinary drugs are pushing veterinarians toward compounding alternatives. Expanding veterinary clinics and hospital networks also contribute to market growth.

Business Opportunity:

The market presents strong opportunities for pharmaceutical companies and compounding pharmacies to expand service offerings. Digital prescription platforms and tele-veterinary services are creating new distribution channels. Investments in automated compounding systems and quality assurance technologies can significantly improve efficiency and scalability. Partnerships between veterinarians and compounding pharmacies are expected to increase, creating long-term business growth prospects.

Region Analysis:

The United States dominates the North America vet compounding pharmacies market due to its large pet population and advanced veterinary healthcare system. Canada is also witnessing steady growth supported by increasing awareness of animal health and supportive regulatory frameworks. Urban regions are particularly driving demand due to higher pet ownership and better access to veterinary services. The region benefits from strong R&D investment and presence of established pharmaceutical companies.

Key Players:

  • Hoye's Pharmacy
  • Vertisis Custom Pharmacy
  • Smith Caldwell Drug Store
  • Sixth Avenue Medical Pharmacy
  • Dougherty Pharmacy
  • Triangle Compounding Pharmacy Inc.,
  • Wedgewood Pharmacy
  • Millers Pharmacy
  • Chiron Compounding Pharmacy
  • MEDS Canadian Compounding Pharmacy

Market Segmentation

By Product Type :

  • CNS Agents
  • Anti-infective Agents
  • Hormones and Substitutes
  • Anti-inflammatory Agents
  • Others

By Animal Type :

  • Companion Animals
  • Livestock Animals

By Formulation :

  • Oral
  • Injectable
  • Others

By Region :

  • North America
  • Europe
  • Latin America
  • East Asia
  • South Asia and Oceania
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global North America Vet Compounding Pharmacies Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2026
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Porter's Five Forces Analysis
  • 2.6. Impact of Russia-Ukraine Conflict
  • 2.7. PESTLE Analysis
  • 2.8. Regulatory Analysis
  • 2.9. Price Trend Analysis
    • 2.9.1. Current Prices and Future Projections, 2025-2033
    • 2.9.2. Price Impact Factors

3. Global North America Vet Compounding Pharmacies Market Outlook, 2020 - 2033

  • 3.1. Global North America Vet Compounding Pharmacies Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
    • 3.1.1. CNS Agents
    • 3.1.2. Anti-Infective Agents
    • 3.1.3. Hormones and Substitutes
    • 3.1.4. Anti-inflammatory Agents
  • 3.2. Global North America Vet Compounding Pharmacies Market Outlook, by Animal Type, Value (US$ Bn), 2020-2033
    • 3.2.1. Companion Animals
      • 3.2.1.1. Dogs
      • 3.2.1.2. Cats
      • 3.2.1.3. Others
    • 3.2.2. Livestock Animals
  • 3.3. Global North America Vet Compounding Pharmacies Market Outlook, by Formulations, Value (US$ Bn), 2020-2033
    • 3.3.1. Oral
    • 3.3.2. Injectable
    • 3.3.3. Others
  • 3.4. Global North America Vet Compounding Pharmacies Market Outlook, by Region, Value (US$ Bn), 2020-2033
    • 3.4.1. North America
    • 3.4.2. Europe
    • 3.4.3. Asia Pacific
    • 3.4.4. Latin America
    • 3.4.5. Middle East & Africa

4. North America North America Vet Compounding Pharmacies Market Outlook, 2020 - 2033

  • 4.1. North America North America Vet Compounding Pharmacies Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
    • 4.1.1. CNS Agents
    • 4.1.2. Anti-Infective Agents
    • 4.1.3. Hormones and Substitutes
    • 4.1.4. Anti-inflammatory Agents
  • 4.2. North America North America Vet Compounding Pharmacies Market Outlook, by Animal Type, Value (US$ Bn), 2020-2033
    • 4.2.1. Companion Animals
      • 4.2.1.1. Dogs
      • 4.2.1.2. Cats
      • 4.2.1.3. Others
    • 4.2.2. Livestock Animals
  • 4.3. North America North America Vet Compounding Pharmacies Market Outlook, by Formulations, Value (US$ Bn), 2020-2033
    • 4.3.1. Oral
    • 4.3.2. Injectable
    • 4.3.3. Others
  • 4.4. North America North America Vet Compounding Pharmacies Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 4.4.1. U.S. North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
    • 4.4.2. U.S. North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
    • 4.4.3. U.S. North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
    • 4.4.4. Canada North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
    • 4.4.5. Canada North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
    • 4.4.6. Canada North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
  • 4.5. BPS Analysis/Market Attractiveness Analysis

5. Europe North America Vet Compounding Pharmacies Market Outlook, 2020 - 2033

  • 5.1. Europe North America Vet Compounding Pharmacies Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
    • 5.1.1. CNS Agents
    • 5.1.2. Anti-Infective Agents
    • 5.1.3. Hormones and Substitutes
    • 5.1.4. Anti-inflammatory Agents
  • 5.2. Europe North America Vet Compounding Pharmacies Market Outlook, by Animal Type, Value (US$ Bn), 2020-2033
    • 5.2.1. Companion Animals
      • 5.2.1.1. Dogs
      • 5.2.1.2. Cats
      • 5.2.1.3. Others
    • 5.2.2. Livestock Animals
  • 5.3. Europe North America Vet Compounding Pharmacies Market Outlook, by Formulations, Value (US$ Bn), 2020-2033
    • 5.3.1. Oral
    • 5.3.2. Injectable
    • 5.3.3. Others
  • 5.4. Europe North America Vet Compounding Pharmacies Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 5.4.1. Germany North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
    • 5.4.2. Germany North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
    • 5.4.3. Germany North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
    • 5.4.4. Italy North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
    • 5.4.5. Italy North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
    • 5.4.6. Italy North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
    • 5.4.7. France North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
    • 5.4.8. France North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
    • 5.4.9. France North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
    • 5.4.10. U.K. North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
    • 5.4.11. U.K. North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
    • 5.4.12. U.K. North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
    • 5.4.13. Spain North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
    • 5.4.14. Spain North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
    • 5.4.15. Spain North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
    • 5.4.16. Russia North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
    • 5.4.17. Russia North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
    • 5.4.18. Russia North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
    • 5.4.19. Rest of Europe North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
    • 5.4.20. Rest of Europe North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
    • 5.4.21. Rest of Europe North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
  • 5.5. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific North America Vet Compounding Pharmacies Market Outlook, 2020 - 2033

  • 6.1. Asia Pacific North America Vet Compounding Pharmacies Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
    • 6.1.1. CNS Agents
    • 6.1.2. Anti-Infective Agents
    • 6.1.3. Hormones and Substitutes
    • 6.1.4. Anti-inflammatory Agents
  • 6.2. Asia Pacific North America Vet Compounding Pharmacies Market Outlook, by Animal Type, Value (US$ Bn), 2020-2033
    • 6.2.1. Companion Animals
      • 6.2.1.1. Dogs
      • 6.2.1.2. Cats
      • 6.2.1.3. Others
    • 6.2.2. Livestock Animals
  • 6.3. Asia Pacific North America Vet Compounding Pharmacies Market Outlook, by Formulations, Value (US$ Bn), 2020-2033
    • 6.3.1. Oral
    • 6.3.2. Injectable
    • 6.3.3. Others
  • 6.4. Asia Pacific North America Vet Compounding Pharmacies Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 6.4.1. China North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
    • 6.4.2. China North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
    • 6.4.3. China North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
    • 6.4.4. Japan North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
    • 6.4.5. Japan North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
    • 6.4.6. Japan North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
    • 6.4.7. South Korea North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
    • 6.4.8. South Korea North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
    • 6.4.9. South Korea North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
    • 6.4.10. India North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
    • 6.4.11. India North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
    • 6.4.12. India North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
    • 6.4.13. Southeast Asia North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
    • 6.4.14. Southeast Asia North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
    • 6.4.15. Southeast Asia North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
    • 6.4.16. Rest of SAO North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
    • 6.4.17. Rest of SAO North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
    • 6.4.18. Rest of SAO North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
  • 6.5. BPS Analysis/Market Attractiveness Analysis

7. Latin America North America Vet Compounding Pharmacies Market Outlook, 2020 - 2033

  • 7.1. Latin America North America Vet Compounding Pharmacies Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
    • 7.1.1. CNS Agents
    • 7.1.2. Anti-Infective Agents
    • 7.1.3. Hormones and Substitutes
    • 7.1.4. Anti-inflammatory Agents
  • 7.2. Latin America North America Vet Compounding Pharmacies Market Outlook, by Animal Type, Value (US$ Bn), 2020-2033
    • 7.2.1. Companion Animals
      • 7.2.1.1. Dogs
      • 7.2.1.2. Cats
      • 7.2.1.3. Others
    • 7.2.2. Livestock Animals
  • 7.3. Latin America North America Vet Compounding Pharmacies Market Outlook, by Formulations, Value (US$ Bn), 2020-2033
    • 7.3.1. Oral
    • 7.3.2. Injectable
    • 7.3.3. Others
  • 7.4. Latin America North America Vet Compounding Pharmacies Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 7.4.1. Brazil North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
    • 7.4.2. Brazil North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
    • 7.4.3. Brazil North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
    • 7.4.4. Mexico North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
    • 7.4.5. Mexico North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
    • 7.4.6. Mexico North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
    • 7.4.7. Argentina North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
    • 7.4.8. Argentina North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
    • 7.4.9. Argentina North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
    • 7.4.10. Rest of LATAM North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
    • 7.4.11. Rest of LATAM North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
    • 7.4.12. Rest of LATAM North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
  • 7.5. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa North America Vet Compounding Pharmacies Market Outlook, 2020 - 2033

  • 8.1. Middle East & Africa North America Vet Compounding Pharmacies Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
    • 8.1.1. CNS Agents
    • 8.1.2. Anti-Infective Agents
    • 8.1.3. Hormones and Substitutes
    • 8.1.4. Anti-inflammatory Agents
  • 8.2. Middle East & Africa North America Vet Compounding Pharmacies Market Outlook, by Animal Type, Value (US$ Bn), 2020-2033
    • 8.2.1. Companion Animals
      • 8.2.1.1. Dogs
      • 8.2.1.2. Cats
      • 8.2.1.3. Others
    • 8.2.2. Livestock Animals
  • 8.3. Middle East & Africa North America Vet Compounding Pharmacies Market Outlook, by Formulations, Value (US$ Bn), 2020-2033
    • 8.3.1. Oral
    • 8.3.2. Injectable
    • 8.3.3. Others
  • 8.4. Middle East & Africa North America Vet Compounding Pharmacies Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 8.4.1. GCC North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
    • 8.4.2. GCC North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
    • 8.4.3. GCC North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
    • 8.4.4. South Africa North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
    • 8.4.5. South Africa North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
    • 8.4.6. South Africa North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
    • 8.4.7. Egypt North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
    • 8.4.8. Egypt North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
    • 8.4.9. Egypt North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
    • 8.4.10. Nigeria North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
    • 8.4.11. Nigeria North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
    • 8.4.12. Nigeria North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
    • 8.4.13. Rest of Middle East North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
    • 8.4.14. Rest of Middle East North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
    • 8.4.15. Rest of Middle East North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
  • 8.5. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Vs Segment Heatmap
  • 9.2. Company Market Share Analysis, 2025
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Hoye's Pharmacy
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Developments
    • 9.4.2. Vertisis Custom Pharmacy
    • 9.4.3. Smith Caldwell Drug Store
    • 9.4.4. Sixth Avenue Medical Pharmacy
    • 9.4.5. Dougherty Pharmacy
    • 9.4.6. Triangle Compounding Pharmacy Inc.,
    • 9.4.7. Wedgewood Pharmacy
    • 9.4.8. Millers Pharmacy
    • 9.4.9. Chiron Compounding Pharmacy
    • 9.4.10. MEDS Canadian Compounding Pharmacy

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations